Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Buy
Debt to Equity Rating
Strong Buy
Price to Earnings Rating
Neutral
Analyst Rating
Strong Buy
Simple Moving Average
Strong Buy
Exponential Moving Average
Strong Buy
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Neutral
Wall Street Data Solutions Rating
Buy
A
Prestige Consumer Healthcare Inc. (PBH)
Pharmaceutical Preparations
https://www.prestigebrands.com
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
660 WHITE PLAINS RD.
TARRYTOWN, NY
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
02/10/2005
Market Cap
3,396,664,196
Shares Outstanding
49,620,000
Weighted SO
49,618,585
Total Employees
N/A
Upcoming Earnings
08/08/2024
Beta
0.4910
Last Div
0.0000
Range
56.34-75.31
Chg
-0.1500
Avg Vol
265309
Mkt Cap
3396664196
Exch
NYSE
Country
US
Phone
914 524 6800
DCF Diff
-135.3741
DCF
203.6540
Div Yield
0.0000
P/S
3.0513
EV Multiple
12.4849
P/FV
2.0343
Div Yield %
0.0000
P/E
16.6683
PEG
3.9875
Payout
0.0000
Current Ratio
3.2313
Quick Ratio
1.8990
Cash Ratio
0.3002
DSO
56.2965
DIO
109.0745
Op Cycle
165.3710
DPO
28.3777
CCC
136.9932
Gross Margin
0.5430
Op Margin
0.2958
Pretax Margin
0.2387
Net Margin
0.1843
Eff Tax Rate
0.2280
ROA
0.0620
ROE
0.1268
ROCE
0.1031
NI/EBT
0.7720
EBT/EBIT
0.8070
EBIT/Rev
0.2958
Debt Ratio
0.3313
D/E
0.6519
LT Debt/Cap
0.3937
Total Debt/Cap
0.3946
Int Coverage
5.2619
CF/Debt
0.2333
Equity Multi
1.9679
Rec Turnover
6.4835
Pay Turnover
12.8622
Inv Turnover
3.3463
FA Turnover
12.9016
Asset Turnover
0.3366
OCF/Share
5.1240
FCF/Share
4.9391
Cash/Share
0.6867
OCF/Sales
0.2296
FCF/OCF
0.9639
CF Coverage
0.2333
ST Coverage
57.4545
CapEx Coverage
27.7089
Div&CapEx Cov
27.7089
P/BV
2.0343
P/B
2.0343
P/S
3.0513
P/E
16.6683
P/FCF
13.7857
P/OCF
13.3763
P/CF
13.3763
PEG
3.9875
P/S
3.0513
EV Multiple
12.4849
P/FV
2.0343
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Dividend History
Cash Value | Ex-Dividend Date | Declaration Date | Record Date | Pay Date |
---|---|---|---|---|
0.48 | 09/27/2018 | 11/30/-0001 | 11/30/-0001 | 10/15/2018 |
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
145.70K Shares Bought (66.36 %)
73.86K Shares Sold (33.64%)
3 - 6 Months
82.23K Shares Bought (32.64 %)
169.67K Shares Sold (67.36%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
49.11K Shares Bought (41.00 %)
70.68K Shares Sold (59.00 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 255.97M | ▼ 241.03M | ▲ 251.24M | ▼ 237.76M | ▲ 266.94M | ▲ 285.87M | ▼ 276.99M |
Cost Of Revenue | 114.71M | ▼ 102.78M | ▲ 107.33M | ▼ 100.71M | ▲ 118.07M | ▲ 132.11M | ▼ 130.86M |
Gross Profit | 141.26M | ▼ 138.25M | ▲ 143.91M | ▼ 137.06M | ▲ 148.86M | ▲ 153.76M | ▼ 146.13M |
Gross Profit Ratio | 0.55 | ▲ 0.57 | ▼ 0.57 | ▲ 0.58 | ▼ 0.56 | ▼ 0.54 | ▼ 0.53 |
Research And Development Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General And Administrative Expenses | 121.82M | ▼ 21.30M | ▲ 23.58M | ▲ 23.82M | ▲ 27.81M | ▼ 27.67M | ▼ 26.47M |
Selling And Marketing Expenses | 35.32M | ▼ 34.43M | ▲ 40.17M | ▼ 36.42M | ▲ 36.94M | ▼ 30.87M | ▲ 37.52M |
Selling General And Administrative Expenses | 157.13M | ▼ 55.73M | ▲ 63.75M | ▼ 60.24M | ▲ 64.75M | ▼ 58.53M | ▲ 63.98M |
Other Expenses | 6.95M | ▼ 164.00K | ▼ -930.00K | ▲ 746.00K | ▲ 6.69M | ▼ 6.01M | ▼ 429.00K |
Operating Expenses | 164.08M | ▼ 62.23M | ▲ 69.99M | ▼ 66.12M | ▲ 71.44M | ▼ 64.54M | ▼ 63.98M |
Cost And Expenses | 278.79M | ▼ 165.01M | ▲ 177.32M | ▼ 166.82M | ▲ 189.51M | ▲ 196.65M | ▼ 194.84M |
Interest Income | 115.00K | ▼ 45.00K | ▼ 22.00K | ▼ -24.00K | ▲ 0.00 | ▲ 18.98M | ▼ 0.00 |
Interest Expense | 26.95M | ▼ 25.79M | ▼ 22.47M | ▼ 18.98M | ▼ 15.97M | ▲ 18.98M | ▼ 15.26M |
Depreciation And Amortization | 6.95M | ▼ 6.50M | ▼ 6.24M | ▼ 5.88M | ▲ 6.21M | ▼ 6.01M | ▲ 7.84M |
Ebitda | -15.76M | ▲ 82.72M | ▼ 79.25M | ▼ 77.56M | ▲ 83.63M | ▲ 95.68M | ▼ 90.00M |
Ebitda Ratio | -0.06 | ▲ 0.34 | ▼ 0.32 | ▲ 0.33 | ▼ 0.31 | ▲ 0.33 | ▼ 0.32 |
Operating Income | -22.82M | ▼ -153.45M | ▲ 73.92M | ▼ 70.94M | ▲ 77.43M | ▲ 89.67M | ▼ 82.15M |
Operating Income Ratio | -0.09 | ▼ -0.64 | ▲ 0.29 | ▲ 0.30 | ▼ 0.29 | ▲ 0.31 | ▼ 0.30 |
Total Other Income Expenses Net | -2.90M | ▼ -229.30M | ▲ -930.00K | ▼ -11.58M | ▼ -16.46M | ▼ -389.19M | ▲ -14.83M |
Income Before Tax | -52.56M | ▼ -179.03M | ▲ 50.54M | ▼ 40.37M | ▲ 60.97M | ▼ -299.52M | ▲ 67.32M |
Income Before Tax Ratio | -0.21 | ▼ -0.74 | ▲ 0.20 | ▼ 0.17 | ▲ 0.23 | ▼ -1.05 | ▲ 0.24 |
Income Tax Expense | -12.88M | ▼ -39.76M | ▲ 13.49M | ▼ 4.86M | ▲ 8.88M | ▼ -58.97M | ▲ 17.86M |
Net Income | -39.69M | ▼ -139.27M | ▲ 37.05M | ▼ 35.51M | ▲ 52.09M | ▼ -240.55M | ▲ 49.46M |
Net Income Ratio | -0.16 | ▼ -0.58 | ▲ 0.15 | ▲ 0.15 | ▲ 0.20 | ▼ -0.84 | ▲ 0.18 |
Eps | -0.75 | ▼ -2.68 | ▲ 0.74 | ▼ 0.71 | ▲ 1.02 | ▼ -4.83 | ▲ 0.99 |
Eps Diluted | -0.75 | ▼ -2.68 | ▲ 0.73 | ▼ 0.70 | ▲ 1.02 | ▼ -4.83 | ▲ 0.98 |
Weighted Average Shs Out | 53.13M | ▼ 51.91M | ▼ 50.37M | ▼ 50.03M | ▲ 50.36M | ▼ 49.80M | ▲ 49.83M |
Weighted Average Shs Out Dil | 53.13M | ▼ 51.91M | ▼ 50.88M | ▼ 50.51M | ▲ 50.97M | ▼ 49.80M | ▲ 50.31M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 32.55M | ▼ 27.53M | ▲ 94.76M | ▼ 32.30M | ▼ 27.19M | ▲ 58.49M | ▼ 46.47M |
Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 32.55M | ▼ 27.53M | ▲ 94.76M | ▼ 32.30M | ▼ 27.19M | ▲ 58.49M | ▼ 46.47M |
Net Receivables | 140.88M | ▲ 148.79M | ▲ 150.52M | ▼ 114.67M | ▲ 139.33M | ▲ 167.02M | ▲ 176.78M |
Inventory | 118.55M | ▲ 119.88M | ▼ 116.03M | ▼ 114.96M | ▲ 120.34M | ▲ 162.12M | ▼ 138.72M |
Other Current Assets | 11.48M | ▼ 4.74M | ▼ 4.35M | ▲ 7.90M | ▼ 6.41M | ▼ 4.12M | ▲ 13.08M |
Total Current Assets | 303.48M | ▼ 300.94M | ▲ 365.65M | ▼ 269.84M | ▲ 293.27M | ▲ 391.74M | ▼ 375.04M |
Property Plant Equipment Net | 52.55M | ▼ 51.18M | ▲ 90.72M | ▲ 102.77M | ▼ 98.53M | ▼ 89.54M | ▼ 89.33M |
Goodwill | 620.10M | ▼ 578.58M | ▼ 575.18M | ▲ 578.08M | ▲ 578.98M | ▼ 527.55M | ▲ 527.73M |
Intangible Assets | 2.78B | ▼ 2.51B | ▼ 2.48B | ▼ 2.48B | ▲ 2.70B | ▼ 2.34B | ▼ 2.32B |
Goodwill And Intangible Assets | 3.40B | ▼ 3.09B | ▼ 3.05B | ▼ 3.05B | ▲ 3.28B | ▼ 2.87B | ▼ 2.85B |
Long Term Investments | -26.00K | ▼ -399.58M | ▲ 0.00 | ▼ -39.78M | ▼ -444.92M | ▲ 0.00 | ▼ -403.60M |
Tax Assets | 26.00K | ▲ 399.58M | ▼ 0.00 | ▲ 39.78M | ▲ 444.92M | ▼ 380.43M | ▼ 38.49M |
Other Non Current Assets | 3.54M | ▼ -396.45M | ▲ 2.96M | ▼ -36.91M | ▲ 3.27M | ▼ -377.43M | ▲ 409.32M |
Total Non Current Assets | 3.46B | ▼ 3.14B | ▲ 3.15B | ▲ 3.16B | ▲ 3.38B | ▼ 2.96B | ▲ 2.98B |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Total Assets | 3.76B | ▼ 3.44B | ▲ 3.51B | ▼ 3.43B | ▲ 3.67B | ▼ 3.35B | ▲ 3.36B |
Account Payables | 61.39M | ▼ 56.56M | ▲ 62.38M | ▼ 45.98M | ▲ 55.76M | ▲ 62.74M | ▼ 38.98M |
Short Term Debt | 0.00 | 0.00 | ▲ 6.83M | ▲ 8.45M | ▲ 9.11M | ▲ 9.76M | ▼ 6.15M |
Tax Payables | 1.90M | ▼ 88.00K | ▲ 5.13M | ▼ 4.02M | ▼ 2.68M | ▲ 10.65M | ▼ 2.57M |
Deferred Revenue | 0.00 | 0.00 | ▲ 407.81M | ▲ 434.05M | ▼ 0.00 | 0.00 | ▲ 2.57M |
Other Current Liabilities | 61.81M | ▲ 70.42M | ▼ -327.14M | ▼ -366.34M | ▲ 78.55M | ▲ 88.21M | ▼ 69.35M |
Total Current Liabilities | 123.20M | ▲ 126.98M | ▲ 149.88M | ▼ 122.14M | ▲ 143.42M | ▲ 160.72M | ▼ 117.05M |
Long Term Debt | 1.99B | ▼ 1.80B | ▼ 1.76B | ▼ 1.51B | ▼ 1.50B | ▼ 1.36B | ▼ 1.13B |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 46.19M |
Deferred Tax Liabilities Non Current | 442.52M | ▼ 399.58M | ▲ 407.81M | ▲ 434.05M | ▲ 444.92M | ▼ 380.43M | ▲ 442.08M |
Other Non Current Liabilities | 23.33M | ▼ 20.05M | ▲ 25.44M | ▼ 8.61M | ▼ 7.48M | ▲ 8.17M | ▼ -29.30M |
Total Non Current Liabilities | 2.46B | ▼ 2.22B | ▼ 2.19B | ▼ 1.95B | ▲ 1.95B | ▼ 1.75B | ▼ 1.58B |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | 0.00 | ▲ 36.34M | ▼ 34.97M | ▼ 29.70M | ▼ 21.30M | ▼ 7.70M |
Total Liabilities | 2.58B | ▼ 2.35B | ▼ 2.34B | ▼ 2.07B | ▲ 2.09B | ▼ 1.91B | ▼ 1.70B |
Preferred Stock | 315.00K | ▼ 0.00 | ▲ 161.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 534.00K | ▲ 536.00K | ▲ 538.00K | ▲ 540.00K | ▲ 544.00K | ▲ 548.00K | ▲ 555.00K |
Retained Earnings | 736.28M | ▼ 701.82M | ▲ 844.10M | ▲ 1.01B | ▲ 1.21B | ▼ 1.13B | ▲ 1.34B |
Accumulated Other Comprehensive Income Loss | -19.32M | ▼ -25.75M | ▼ -44.16M | ▲ -19.80M | ▲ -19.03M | ▼ -31.56M | ▼ -34.50M |
Other Total Stockholders Equity | 460.80M | ▼ 419.22M | ▼ 370.33M | ▼ 368.78M | ▲ 381.94M | ▼ 346.24M | ▲ 347.83M |
Total Stockholders Equity | 1.18B | ▼ 1.10B | ▲ 1.17B | ▲ 1.36B | ▲ 1.58B | ▼ 1.45B | ▲ 1.66B |
Total Equity | 1.18B | ▼ 1.10B | ▲ 1.17B | ▲ 1.36B | ▲ 1.58B | ▼ 1.45B | ▲ 1.66B |
Total Liabilities And Stockholders Equity | 3.76B | ▼ 3.44B | ▲ 3.51B | ▼ 3.43B | ▲ 3.67B | ▼ 3.35B | ▲ 3.36B |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 3.76B | ▼ 3.44B | ▲ 3.51B | ▼ 3.43B | ▲ 3.67B | ▼ 3.35B | ▲ 3.36B |
Total Investments | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -444.92M | ▲ 0.00 | ▼ -403.60M |
Total Debt | 1.99B | ▼ 1.80B | ▼ 1.77B | ▼ 1.51B | ▼ 1.51B | ▼ 1.37B | ▼ 1.14B |
Net Debt | 1.96B | ▼ 1.77B | ▼ 1.67B | ▼ 1.48B | ▼ 1.48B | ▼ 1.31B | ▼ 1.09B |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -139.27M | ▲ 37.05M | ▼ 35.51M | ▲ 52.09M | ▼ 0.00 | ▼ -240.55M | ▲ 49.46M |
Depreciation And Amortization | 7.53M | ▼ 7.33M | ▲ 7.54M | ▲ 8.49M | ▼ 0.00 | ▲ 7.86M | ▼ 7.84M |
Deferred Income Tax | -43.86M | ▲ 6.47M | ▲ 10.66M | ▼ -1.32M | ▲ 0.00 | ▼ -74.79M | ▲ 8.18M |
Stock Based Compensation | 1.28M | ▲ 1.96M | ▲ 2.60M | ▼ 1.71M | ▼ 0.00 | ▲ 2.65M | ▲ 3.73M |
Change In Working Capital | -5.85M | ▲ -976.00K | ▼ -6.33M | ▲ -2.17M | ▲ 0.00 | ▼ -9.87M | ▲ -5.51M |
Accounts Receivables | -8.38M | ▲ -7.47M | ▲ 147.00K | ▼ -2.81M | ▲ 0.00 | ▼ -7.85M | ▲ 695.00K |
Inventory | 546.00K | ▲ 3.75M | ▼ 1.70M | ▼ -13.99M | ▲ 0.00 | ▼ -3.64M | ▲ 10.65M |
Accounts Payables | 8.79M | ▲ 12.30M | ▲ 18.45M | ▼ 15.23M | ▼ 0.00 | ▼ -1.63M | ▲ -1.01M |
Other Working Capital | -6.82M | ▼ -9.55M | ▼ -26.63M | ▲ -607.00K | ▲ 0.00 | ▲ 3.25M | ▼ -15.85M |
Other Non Cash Items | 231.03M | ▼ 4.29M | ▲ 9.11M | ▼ 4.33M | ▼ 0.00 | ▲ 373.68M | ▼ 12.29M |
Net Cash Provided By Operating Activities | 50.85M | ▲ 56.13M | ▲ 59.09M | ▲ 63.13M | ▼ 0.00 | ▲ 58.99M | ▲ 66.91M |
Investments In Property Plant And Equipment | -3.34M | ▼ -8.27M | ▲ -4.90M | ▲ -3.16M | ▲ 0.00 | ▼ -2.56M | ▼ -3.14M |
Acquisitions Net | 0.00 | 0.00 | 0.00 | ▼ -132.00K | ▲ 0.00 | 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | ▼ -2.76M | ▲ 0.00 | ▼ -18.13M | ▲ 0.00 | ▼ -3.80M | ▼ -11.86M |
Net Cash Used For Investing Activities | -3.34M | ▼ -8.27M | ▲ -4.90M | ▲ -3.29M | ▲ 0.00 | ▼ -6.36M | ▼ -15.00M |
Debt Repayment | -45.00M | ▲ -27.22M | ▼ -665.53M | ▲ -55.44M | ▲ 0.00 | ▼ -80.69M | ▲ -75.72M |
Common Stock Issued | 0.00 | 0.00 | ▲ 1.53M | ▼ 1.32M | ▼ 0.00 | ▲ 7.37M | ▼ 7.27M |
Common Stock Repurchased | 0.00 | ▼ -6.75M | ▲ -1.99M | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 155.00M | ▼ 54.53M | ▲ 583.81M | ▼ 1.32M | ▼ 0.00 | ▼ -7.17M | ▲ 7.27M |
Net Cash Used Provided By Financing Activities | -45.00M | ▲ 20.56M | ▼ -83.71M | ▲ -54.12M | ▲ 0.00 | ▼ -80.50M | ▲ -68.44M |
Effect Of Forex Changes On Cash | 352.00K | ▼ -2.25M | ▲ -283.00K | ▲ 449.00K | ▼ 0.00 | ▼ -3.00K | ▼ -605.00K |
Net Change In Cash | 2.86M | ▲ 66.17M | ▼ -29.80M | ▲ 6.17M | ▼ 0.00 | ▼ -27.87M | ▲ -17.15M |
Cash At End Of Period | 27.53M | ▲ 94.76M | ▼ 32.30M | ▼ 27.19M | ▼ 0.00 | ▲ 58.49M | ▼ 46.47M |
Cash At Beginning Of Period | 24.67M | ▲ 28.59M | ▲ 62.10M | ▼ 21.02M | ▼ 0.00 | ▲ 86.36M | ▼ 63.62M |
Operating Cash Flow | 50.85M | ▲ 56.13M | ▲ 59.09M | ▲ 63.13M | ▼ 0.00 | ▲ 58.99M | ▲ 66.91M |
Capital Expenditure | -3.34M | ▼ -8.27M | ▲ -4.90M | ▲ -3.16M | ▲ 0.00 | ▼ -2.56M | ▼ -3.14M |
Free Cash Flow | 47.51M | ▲ 47.86M | ▲ 54.19M | ▲ 59.97M | ▼ 0.00 | ▲ 56.43M | ▲ 63.76M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)